Information sur le laboratoire
Talat Bessissow (M.D./M.Sc.)
ChercheurUnité de recherche clinique
Département de médecine (McGill)
Profil de recherche
Mots-clés
Maladie de Crohn • colite ulcéreuse • cicatrisation des muqueuses • néoplasme • pathogenèseIntérêts de recherche
Ma recherche porte sur le rôle de la cicatrisation des muqueuses dans le traitement de la maladie inflammatoire chronique de l'intestin. Je m'intéresse également à l'identification des facteurs qui prédisent la rechute de la maladie.Membre de l'équipe
| Nom | Poste |
|---|
Dernières publications
- Ngew, E., Stobbs, J. A., Bessissow, T. & George, S. (2026). A modified synchrotron X-ray phase-contrast micro-CT workflow for non-destructive 3D imaging of intestinal biopsies. Talanta, vol. 309, p. 130019.
- Aboulhamid, N., Zoughlami, A., Evaristo, G. & Bessissow, T. (2026). Rare Rectal Involvement of Metastatic Appendiceal Adenocarcinoma Mimicking Primary Rectal Cancer. ACG case reports journal, vol. 13, p. e02045.
- Jairath, V., Bessissow, T., Glass, J., Braun, M., Gibble, T. H., Movsessian, T., Atkinson, C., Ellis, H., Dewar, T. & Panaccione, R. (2026). Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn's disease. Journal of the Canadian Association of Gastroenterology, vol. 9, p. 38-48.
- Kritzinger, J., Candel, I., Kotrri, G., Nadeem, H., Afif, W., Bitton, A., Wild, G., Bessissow, T. & Lakatos, P. L. (2025). Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease. World journal of gastroenterology, vol. 31, p. 114355.
- Isnard, S., Berini, C. A., Parvathy, S. N., Feng, H., Aiyana, O., Royston, L., Mabanga, T., Lakatos, P. L., Bessissow, T., Klein, M. B., Lebouché, B., Costiniuk, C. T., Routy, B., Silverman, M. S. & Routy, J.-P. (2025). Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038). Trials, vol. 27, p. 52.
- Hagh-Doust, H., Nadeem, H., Bessissow, T. & Lakatos, P. L. (2025). New-Onset Ulcerative Colitis after Secukinumab Initiation: A Case Report. Case reports in gastroenterology, vol. 19, p. 726-730.
- Shebab, M., Al-Hindawi, A., Goodwin, S. W., Yuan, Y., Bessissow, T., Peyrin-Biroulet, L. & Jairath, V. (2026). Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel disease. The lancet. Gastroenterology & hepatology, vol. 11, p. 89-91.
- Soublette Figuera, A., Alessa, S., Brien, C., Hendrickson, M., Kasvis, P. & Bessissow, T. (2025). Effects of Ultra-Processed Foods and Food Additives on Disease Activity in Adults with Inflammatory Bowel Disease: A Scoping Review. Journal of clinical medicine, vol. 14.
- Pedicelli, A., Bessissow, T. & Afif, W. (2025). Personalizing IL-23 Inhibitor Therapy in IBD: Current Evidence and Future Directions in Therapeutic Drug Monitoring and Dose Optimization. Journal of clinical medicine, vol. 14.
- Al Alawi, S., Bessissow, T., Tsoukas, S., Ureña Campos, R., Lu, Y., Chen, Y.-I. & Jacques, J. (2025). Combination of underwater and traction-assisted endoscopic submucosal dissection: the perfect wedding for a challenging case. Endoscopy, vol. 57, p. E1233-E1234.
Voir aussi
